Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 25129854)

1.

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer.

Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, Wang D, See W, Costello BA, Quevedo F, Tan W, Nandy D, Bevan GH, Longenbach S, Sun Z, Lu Y, Wang T, Thibodeau SN, Boardman L, Kohli M, Wang L.

Eur Urol. 2015 Jan;67(1):33-41. doi: 10.1016/j.eururo.2014.07.035. Epub 2014 Aug 14.

PMID:
25129854
2.

Prognostic markers in esophageal cancer: from basic research to clinical use.

Hong L, Han Y, Zhang H, Fan D.

Expert Rev Gastroenterol Hepatol. 2015 Jul;9(7):887-9. doi: 10.1586/17474124.2015.1041507. Epub 2015 Jun 11.

PMID:
26067755
3.

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.

Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, Doki Y, Mori M, Ochiya T, Mimori K.

Br J Cancer. 2015 Jun 9. doi: 10.1038/bjc.2015.201. [Epub ahead of print]

PMID:
26057451
4.

A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.

Tang K, Zhou H, Xiao H, Zeng J, Guan W, Guo X, Xu H, Ye Z.

J Exp Clin Cancer Res. 2015 May 21;34(1):53. [Epub ahead of print]

5.

MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1.

Lu K, Liu C, Tao T, Zhang X, Zhang L, Sun C, Wang Y, Chen S, Xu B, Chen M.

FEBS Lett. 2015 Jun 4;589(13):1485-90. doi: 10.1016/j.febslet.2015.04.037. Epub 2015 Apr 30.

PMID:
25936765
6.

In situ single step detection of exosome microRNA using molecular beacon.

Lee JH, Kim JA, Kwon MH, Kang JY, Rhee WJ.

Biomaterials. 2015 Jun;54:116-25. doi: 10.1016/j.biomaterials.2015.03.014. Epub 2015 Mar 31.

PMID:
25907045
7.

Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer.

Aziz A, Kempkensteffen C, May M, Lebentrau S, Burger M, Chun FK, Brookman-May S.

Expert Rev Anticancer Ther. 2015 Jun;15(6):649-66. doi: 10.1586/14737140.2015.1038247. Epub 2015 Apr 23.

PMID:
25905802
8.

Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells.

Liu TT, Arango-Argoty G, Li Z, Lin Y, Kim SW, Dueck A, Ozsolak F, Monaghan AP, Meister G, DeFranco DB, John B.

RNA. 2015 Jun;21(6):1159-72. doi: 10.1261/rna.045559.114. Epub 2015 Apr 22.

PMID:
25904138
9.

Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma.

Li Y, Zhang L, Liu F, Xiang G, Jiang D, Pu X.

Dis Markers. 2015;2015:893594. doi: 10.1155/2015/893594. Epub 2015 Feb 26.

10.

Serum microRNA-205 as a novel biomarker for cervical cancer patients.

Ma Q, Wan G, Wang S, Yang W, Zhang J, Yao X.

Cancer Cell Int. 2014 Aug 22;14:81. doi: 10.1186/s12935-014-0081-0. eCollection 2014.

11.

On-chip surface acoustic wave lysis and ion-exchange nanomembrane detection of exosomal RNA for pancreatic cancer study and diagnosis.

Taller D, Richards K, Slouka Z, Senapati S, Hill R, Go DB, Chang HC.

Lab Chip. 2015 Apr 7;15(7):1656-66. doi: 10.1039/c5lc00036j. Epub 2015 Feb 18.

PMID:
25690152
12.

Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.

Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A.

J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju492. doi: 10.1093/jnci/dju492. Print 2015 Mar.

PMID:
25663689
13.

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.

Roberts MJ, Chow CW, Schirra HJ, Richards R, Buck M, Selth LA, Doi SA, Samaratunga H, Perry-Keene J, Payton D, Yaxley J, Lavin MF, Gardiner RA.

Prostate. 2015 Apr 1;75(5):539-49. doi: 10.1002/pros.22942. Epub 2015 Jan 18.

PMID:
25597828
14.

Constitutively active AR-V7 plays an essential role in the development and progression of castration-resistant prostate cancer.

Qu Y, Dai B, Ye D, Kong Y, Chang K, Jia Z, Yang X, Zhang H, Zhu Y, Shi G.

Sci Rep. 2015 Jan 7;5:7654. doi: 10.1038/srep07654.

15.

miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.

Larne O, Östling P, Haflidadóttir BS, Hagman Z, Aakula A, Kohonen P, Kallioniemi O, Edsjö A, Bjartell A, Lilja H, Lundwall Å, Ceder Y.

Eur Urol. 2014 Dec 30. pii: S0302-2838(14)01280-9. doi: 10.1016/j.eururo.2014.12.025. [Epub ahead of print]

PMID:
25556023
16.

The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.

Clancy C, Joyce MR, Kerin MJ.

Cancer Biomark. 2015 Jan 1;15(2):103-13. doi: 10.3233/CBM-140456.

PMID:
25547322
17.

Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.

Roth P, Keller A, Hoheisel JD, Codo P, Bauer AS, Backes C, Leidinger P, Meese E, Thiel E, Korfel A, Weller M.

Eur J Cancer. 2015 Feb;51(3):382-90. doi: 10.1016/j.ejca.2014.10.028. Epub 2014 Dec 17.

PMID:
25534293
18.

Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.

Su ZX, Zhao J, Rong ZH, Wu YG, Geng WM, Qin CK.

Tumour Biol. 2014 Dec;35(12):12119-25. doi: 10.1007/s13277-014-2516-6. Epub 2014 Nov 22.

PMID:
25416437
19.
20.

miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx: association with patient survival.

Hu A, Huang JJ, Xu WH, Jin XJ, Li JP, Tang YJ, Huang XF, Cui HJ, Sun GB.

Am J Transl Res. 2014 Oct 11;6(5):604-13. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk